NO942715D0 - 4-aryloksy- og 4-aryltiopiperidinderivater - Google Patents

4-aryloksy- og 4-aryltiopiperidinderivater

Info

Publication number
NO942715D0
NO942715D0 NO942715A NO942715A NO942715D0 NO 942715 D0 NO942715 D0 NO 942715D0 NO 942715 A NO942715 A NO 942715A NO 942715 A NO942715 A NO 942715A NO 942715 D0 NO942715 D0 NO 942715D0
Authority
NO
Norway
Prior art keywords
atoms
aryloxy
action
hal
arylthiopiperidine
Prior art date
Application number
NO942715A
Other languages
English (en)
Other versions
NO301477B1 (no
NO942715L (no
Inventor
Helmut Prucher
Rudolf Gottschlich
Gerd Bartozyk
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO942715D0 publication Critical patent/NO942715D0/no
Publication of NO942715L publication Critical patent/NO942715L/no
Publication of NO301477B1 publication Critical patent/NO301477B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
NO942715A 1993-07-21 1994-07-20 4-aryloksy- og 4-aryltiopiperidinderivater NO301477B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4324393A DE4324393A1 (de) 1993-07-21 1993-07-21 4-Aryloxy- und 4-Arylthiopiperidinderivate

Publications (3)

Publication Number Publication Date
NO942715D0 true NO942715D0 (no) 1994-07-20
NO942715L NO942715L (no) 1995-01-23
NO301477B1 NO301477B1 (no) 1997-11-03

Family

ID=6493312

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942715A NO301477B1 (no) 1993-07-21 1994-07-20 4-aryloksy- og 4-aryltiopiperidinderivater

Country Status (21)

Country Link
US (1) US5561145A (no)
EP (1) EP0635505B1 (no)
JP (1) JPH0770117A (no)
KR (1) KR100354303B1 (no)
CN (1) CN1055690C (no)
AT (1) ATE159252T1 (no)
AU (1) AU683886B2 (no)
CA (1) CA2128380C (no)
CZ (1) CZ284544B6 (no)
DE (2) DE4324393A1 (no)
DK (1) DK0635505T3 (no)
ES (1) ES2110660T3 (no)
GR (1) GR3025880T3 (no)
HU (1) HU218912B (no)
NO (1) NO301477B1 (no)
PL (1) PL177692B1 (no)
RU (1) RU2135495C1 (no)
SK (1) SK281630B6 (no)
TW (1) TW401417B (no)
UA (1) UA43828C2 (no)
ZA (1) ZA945340B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134870T3 (es) * 1993-05-01 1999-10-16 Merck Patent Gmbh Antagonistas del receptor de adhesion.
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
ATE170179T1 (de) * 1994-11-02 1998-09-15 Merck Patent Gmbh Adhäsionsrezeptor-antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19524765A1 (de) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19531321A1 (de) * 1995-08-25 1997-02-27 Merck Patent Gmbh Piperidinylmethyloxazolidinone
US5977138A (en) * 1996-08-15 1999-11-02 Schering Corporation Ether muscarinic antagonists
DE19707628A1 (de) 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
US7408067B2 (en) 2002-01-17 2008-08-05 Merck + Co., Inc. Aza-cyclic compounds as modulators of acetylcholine receptors
CA2634701C (en) * 2005-12-21 2014-07-29 Decode Genetics Ehf Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
DE102014010989B4 (de) 2014-07-29 2017-06-14 Kautex Textron Gmbh & Co. Kg Einfüllstutzen für einen Flüssigkeitsbehälter, insbesondere für einen Harnstoffbehälter
US11186564B2 (en) * 2016-08-04 2021-11-30 Sunovion Pharmaceuticals Inc. Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone

Also Published As

Publication number Publication date
HU9402154D0 (en) 1994-09-28
ATE159252T1 (de) 1997-11-15
DE59404319D1 (de) 1997-11-20
CZ284544B6 (cs) 1998-12-16
KR100354303B1 (ko) 2002-12-11
DK0635505T3 (da) 1998-06-02
US5561145A (en) 1996-10-01
NO301477B1 (no) 1997-11-03
CA2128380A1 (en) 1995-01-22
CZ173894A3 (en) 1995-05-17
KR950003290A (ko) 1995-02-16
PL177692B1 (pl) 2000-01-31
ZA945340B (en) 1995-03-01
DE4324393A1 (de) 1995-01-26
HU218912B (hu) 2000-12-28
RU94026079A (ru) 1996-05-27
EP0635505A1 (de) 1995-01-25
HUT71110A (en) 1995-11-28
SK281630B6 (sk) 2001-06-11
CA2128380C (en) 2005-04-12
CN1106008A (zh) 1995-08-02
GR3025880T3 (en) 1998-04-30
EP0635505B1 (de) 1997-10-15
UA43828C2 (uk) 2002-01-15
PL304349A1 (en) 1995-01-23
AU6753694A (en) 1995-02-02
CN1055690C (zh) 2000-08-23
ES2110660T3 (es) 1998-02-16
RU2135495C1 (ru) 1999-08-27
AU683886B2 (en) 1997-11-27
JPH0770117A (ja) 1995-03-14
TW401417B (en) 2000-08-11
NO942715L (no) 1995-01-23
SK85294A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
ATE159252T1 (de) 4-aryloxy- und 4-arylthiopiperidin-derivate
ATE187724T1 (de) Azachinoxaline, verfahren zu ihrer herstellung und ihre verwendung
ES2086094T3 (es) Nuevas alquilamino-mercaptoalquilamidas o una de sus sales cosmeticamente aceptables, y su utilizacion como agentes reductores, en un procedimiento de deformacion permanente de los cabellos.
DE69210967D1 (de) Piperidinyl- und Piperazinyl-Cyclohexanole
ATE124696T1 (de) Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung.
TR199800457T2 (xx) Benzotiyazolon t�revleri.
ATE64925T1 (de) Benzothiazepin-vasodilatoren mit aralkylsubstitution.
ATE116293T1 (de) 1-benzhydrylazetidine, deren herstellung und verwendung als zwischenprodukte zur herstellung von verbindungen mit antimikrobieller wirkung.
FI930236A (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
DE59405510D1 (de) Bausatz zur Ausbildung einer Leuchtenanordnung
FI930367A0 (fi) Puridinderivat
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ATE134681T1 (de) Verwendung von phosphonsäurediglycidylestern als vernetzer bei hydrogelen
ATE124219T1 (de) Von l-glutaminsäure abgeleitete süssungsmittel, verfahren zu ihrer herstellung.
FI891033A (fi) Lim.
DE69404932T2 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
PT538100E (pt) Processo de preparacao de derivados do acido 3-fluoroquinoleicarboxilico
PT96178A (pt) Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral
DE59208855D1 (de) Verwendung von Aminoalkyl-substituierten 5,6-Dihydro-dibenz(b,e)azepin-6,11-dion-11-oximen als antivirale Mittel
DE59300004D1 (de) 2,3-Dihydroxychinoxalinverbindungen.